Lotus Gets $26M Series A: Skin Disease, Wound Healing
By Anette Breindl
Thursday, June 30, 2011
The combination of the words "dermatology start-up," "collagen" and "University of Southern California licensing agreement" leads somewhat naturally to visions of next-generation plumping injections for aging starlets but Lotus Tissue Repair Inc., a Cambridge, Mass.-based start-up that today announced both an exclusive licensing deal with USC and a $26 million Series A financing from Third Rock Ventures, has more serious problems in its sights.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.